CRISPR Therapeutics AG (NASDAQ:CRSP)

59.39
Delayed Data
As of Nov 21
 -8.03 / -11.91%
Today’s Change
22.22
Today|||52-Week Range
74.00
+107.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.1B

Company Description

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.

Contact Information

CRISPR Therapeutics AG
Baarerstrasse 14
Zug Zug 6300
P:(141) 561-3277
Investor Relations:

Employees

Shareholders

Individual stakeholders39.41%
Other institutional21.10%
Mutual fund holders18.19%

Top Executives

There are no executives to display.